Answers are grounded in this paper and cite their sources.
Conference Article| February 01 1994 Amyloidosis in Alzheimer's disease David Allsop; David Allsop *Department of Molecular Neuropathology, SmithKline Beecham Pharmaceuticals, Harlow, Essex CM19 5AD, U.K. Search for other works by this author on: This Site PubMed Google Scholar Carvell H. Williams Carvell H. Williams 1Division of Biochemistry, School of Biology and Biochemistry, The Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, U.K. Search for other works by this author on: This Site PubMed Google Scholar Biochem Soc Trans (1994) 22 (1): 171–175. https://doi.org/10.1042/bst0220171 Article history Received: September 27 1993 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation David Allsop, Carvell H. Williams; Amyloidosis in Alzheimer's disease. Biochem Soc Trans 1 February 1994; 22 (1): 171–175. doi: https://doi.org/10.1042/bst0220171 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Society Transactions Search Advanced Search Keywords: AD, Alzheimer's disease, APP, amyloid precursor protein, CSF, cerebrospinal fluid, KPI, Kunitz-type protease inhibitor, TIMP-1, tissue inhibitor of metalloproteinases-1, PC, pheochromocytoma, SEC, serpin enzyme complex This content is only available as a PDF.
No takes yet. Share an insight, caveat, or question.
Allsop et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: